TY - JOUR T1 - Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1 JF - Journal for ImmunoTherapy of Cancer JO - J Immunother Cancer DO - 10.1186/s40425-019-0678-x VL - 7 IS - 1 SP - 229 AU - Bridget Marcinkowski AU - Sanja Stevanović AU - Sarah R. Helman AU - Scott M. Norberg AU - Carylinda Serna AU - Benjamin Jin AU - Nikolaos Gkitsas AU - Tejas Kadakia AU - Andrew Warner AU - Jeremy L. Davis AU - Lisa Rooper AU - Christian S. Hinrichs Y1 - 2019/12/01 UR - http://jitc.bmj.com/content/7/1/229.abstract N2 - T cell receptor (TCR) gene-engineered T cells have shown promise in the treatment of melanoma and synovial cell sarcoma, but their application to epithelial cancers has been limited. The identification of novel therapeutic TCRs for the targeting of these tumors is important for the development of new treatments. Here, we describe the preclinical characterization of a TCR directed against Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1, encoded by CT83), a cancer germline antigen with frequent expression in human epithelial malignancies including gastric cancer, breast cancer, and lung cancer. Gene-engineered T cells expressing the KK-LC-1 TCR (KK-LC-1 TCR-Ts) demonstrated recognition of CT83+ tumor lines in vitro and mediated regression of established CT83+ xenograft tumors in immunodeficient mouse models. Cross-reactivity studies based on experimental determination of the recognition motifs for the target epitope did not demonstrate cross-reactivity against other human proteins. CT83 gene expression studies in 51 non-neural tissues and 24 neural tissues showed expression restricted exclusively to germ cells. CT83 was however expressed by a range of epithelial cancers, with the highest expression noted in gastric cancer. Collectively, these findings support the further investigation and clinical testing of KK-LC-1 TCR-Ts for gastric cancer and possibly other malignancies.Abbreviations:BLASTBasic Local Alignment Search ToolCARsChimeric antigen receptorsCGcancer germlineEBV-LCLsEpstein Barr Virus-transformed lymphoblastoid cell linesELISAenzyme-linked immunosorbent assayIFNinterferonISHin situ hybridizationKK-LC-1Kita-Kyushu Lung Cancer Antigen-1PBMCperipheral blood mononuclear cellsPMAphorbol 12-myristate 13-acetateqRT-PCRquantitative reverse transcription polymerase chain reactionTCGAThe Cancer Genome AtlasTCRT cell receptorTILstumor-infiltrating lymphocytes ER -